🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

After the first 60 days of treatment, thrombosis occurred in 17% of patients who received low-molecular weight heparin compared with 11% of patients who did not receive thromboprophylaxis (adjusted HR, 1.52; 95% CI, 0.79-2.90). #leusm | Mandy Lauw cancernetwork.com/view/low-molec…

🚨🚨🚨 DO NOT MISS THIS OPPORTUNITY!! Apply for European Hematology Association CRTH 2025. Deadline has been extended until September 24, 2024. There are still spots available!! #hematology #research #clinicalresearch #clinicaltrials

Sad that European Hematology Association #CRTH2024 is coming to an end this week but looking forward to 2025 - please consider applying to join us!

#CRTH2024 has come to its end. Amazing scholars, high expertise faculty, extraordinary organization. Thanks to European Hematology Association for this outstanding #mentoring experience. Proud to be part of it. Looking forward to next year edition. Please, apply!! ehaweb.org/research/resea…

#Burnout is a major issue among healthcare professionals and #hematology is no different but hard evidence is lacking. Complete our survey to better understand this 👉 research.net/r/?sm=XpL1E_2F…

🚨Interactions between #food 🥘🍲/🌿& oral #anticoagulants: There's plenty for #warfarin, but few important ones for #DOACs, too! Azita Talasaz, PharmD Seminars in Thrombosis and Hemostasis Brigham and Women’s Research And a lot to study in future #HemeTwitter #CardioTwitter #Thrombosis👇: tinyurl.com/2v373thz

The floor is prepared thanks to both European Hematology Association and DGHO e. V.... Trainees, residents, students from 🇨🇭🇦🇹🇩🇪! Join the movement and engage in JungeDGHO to improve education, representation, and networking! Share your visions. Special 🙏 YoungEHA Andreas Hochhaus at #DGHO24

Personalized medicine getting closer: Impact of the VTE-PREDICT calculator on clinicians’ decision making in fictional patients with venous thromboembolism: a randomized controlled trial - Research and Practice in Thrombosis and Haemostasis rpthjournal.org/article/S2475-…

First joint YoungEHA session at #Serbian national #hematology meeting! Engaging with local #earlycareer hematologists and sharing wisdom & talks on European Hematology Association opportunities by Mandy Lauw, networking & #socialmedia by Ana Zelic Kerep and personal experience by Nikola Pantic

🆕🚨Whether patients taking #DOACs should receive thrombolysis for ischemic stroke is uncertain‼️ Coinciding with #WSC2024, our The BMJ article summarizes the evidence of the uncertainty, highlights ongoing trials & proposes an approach to management. bmj.com/cgi/content/fu…

Erasmus MC virtual Hematology lecture November 4th, 16.00 CET! We have: Job Dekker, University of Massachusetts, Worcester with: "Mechanisms of chromosome folding"! us06web.zoom.us/j/82722159417 ID: 827 2215 9417 Check the poster for the other speakers in 2024!

Rivaroxaban for 18 Months Superior to 6 Months To Prevent Recurrent VTE Events in Cancer Patients with Acute-low PE: ONCO PR Written by Joseph Kim! Summary, analysis and more AHA coverage below! cardiologynownews.org/rivaroxaban-fo… C. Michael Gibson MD

Large multi-national cohort study of pts with MPN and splanchnic vein thrombosis shows high risk of recurrent thrombosis and bleeding in first year - more patients and analyses to come! #ASH24 very proud of Mandy Lauw and colleagues!

Proud of Joan How and our GASTRO-MPN #collaboration presentation today at #ASH24; first results of management and outcomes of splanchnic vein #thrombosis in #MPN. Looking forward to our next steps! ASH ISTH

Saying hi to our amazing ISTH team #ASH24, and look what they had in store fore me! The must-have coagulation clock designed by Jim Morrissey. Join us in Washington DC in June 2025. This will be the PREMIER event in #thrombosis and #haemostasis of 2025!!

Many anticoagulant-related bleedings 🩸 in patients with cancer are attributable to modifiable risk factors. Addressing them (anemia, HTN, anti platelets, alcohol abuse) could improve outcomes in these patients! Kristen Sanfilippo #ASH24

Full room for #thrombosis & #hormones ; 5 key messages by Saskia Middeldorp on role of #anticoagulation and #thrombophilia. Unfortunately due to planning competing sessions on classical #hematology by ASH could not see contributions by Joseph Shatzel and Leslie Skeith

#bleeding remains the most important limitation in patients with #cancer, #thrombosis and #anticoagulation. Kristen Sanfilippo has identified modifiable risk factors for bleeding that may improve outcomes #ASH24